Laparoscopic Nissen Versus Anterior Partial Fundoplication
NCT ID: NCT01669330
Last Updated: 2014-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2001-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conventional Nissen Fundoplication Versus Laparoscopic Nissen Fundoplication
NCT01230944
Laparoscopic Nissen Versus Toupet Fundoplication: Objective and Subjective Results of a Prospective Randomized Trial
NCT01321294
Laparoscopic Nissen Fundoplication Comparing Division Versus Non-Division of Short Gastric Vessels
NCT00852098
A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients
NCT00480285
Laparoscopic Total vs Partial Fundoplication in Patients With Atypical Symptoms of Gastroesophageal Reflux Disease
NCT05647668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Method: All patients operated on for reflux disease in Lund, Malmö,Trollättan and Kalmar are randomised between the two operations. Postoperatively, telephone interview is performed weekly the first two months. One year and ten years postoperatively. The patients are investigated with endoscopy, esophageal manometry, 24 hour pH-monitoring and symptom evaluation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total fundoplication
Procedure: Laparoscopic Nissen fundoplication
Nissen fundoplication
Laparoscopic Nissen fundoplication
Anterior partial fundoplication
Procedure: Laparoscopic anterior partial fundoplication
Laparoscopic antireflux surgery ad modum Watson
Laparoscopic anterior fundoplication
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nissen fundoplication
Laparoscopic Nissen fundoplication
Laparoscopic antireflux surgery ad modum Watson
Laparoscopic anterior fundoplication
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good results of PPI treatment (\<3 months) resulting in reduced heart burn and acid regurgitations.
* Gastroesophageal reflux disease as evidence by gastroscopy and pH-monitoring.
Exclusion Criteria
* Patients with IBS (criteria ROM II)
* Severe disease, for example diabetes mellitus, cardiopulmonary disease or renal disease, that would influence outcome measurement
* Patients with active ulcer disease
* Paraesophageal hernia
* Patient that are incapable to understand the study information (for example mentally disorder, drug abuse)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pauline Djerf, Md
Role: PRINCIPAL_INVESTIGATOR
Region Skane
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery
Kalmar, , Sweden
Department of Surgery
Lund, , Sweden
Department of Surgery
Malmo, , Sweden
Department of Surgery
Trollhättan, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NW20012011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.